ISSN: 1899-0967
Polish Journal of Radiology
Established by prof. Zygmunt Grudziński in 1926 Sun
Current issue Archive About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

vol. 84
Gastrointestinal and abdominal radiology
Original paper

The accuracy of 3T magnetic resonance cholangiopancreatography in suspected choledocholithiasis

Önder Yeniçeri
Neşat Çullu
Burak Özşeker
Emine Neşe Yeniçeri

Faculty of Medicine, Mugla Sitki Kocman University, Turkey
© Pol J Radiol 2019; 84: e419-e423
Online publish date: 2019/10/21
Article file
- The accuracy.pdf  [0.11 MB]
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero


Biliary obstruction may be due to choledocholithiasis, tumours, trauma, or post-surgical strictures. An imaging method is used in conjunction with biochemical parameters for diagnosis. Endoscopic retrograde cholangiography (ERCP) is currently the gold standard diagnostic tool for the imaging of bile ducts [1]. However, the need for general anaesthesia for ERCP creates a disadvantage because it is an invasive and expensive procedure. Magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasonography (EUS) are alternatives to ERCP as a method for noninvasive diagnostic imaging of bile ducts. There are several reports indicating that the sensitivity and specificity of MRCP in choledocholithiasis are 27-90% and 40-100%, respectively [1-6]. The lack of a concomitant therapeutic approach is a disadvantage of this method; for this reason, MRCP is usually followed by an invasive method. Because some reports show that MRCP does not change the management of suspected choledocholithiasis, the benefit for this group of patients is being questioned [2,3].

In literature, the majority of studies conducted on the sensitivity and specificity of MRCP were performed with 1.5T systems due to the widespread use of devices. Initially, SAR problems, coils mismatches, susceptibility artefacts, and penetration failure limited the use of 3T scanners [7]. However, recently the use of 3T scanners has increased by overcoming of these problems and with the development of new sequence structures.

The purpose of this study is to investigate interobserver agreement during MRCP evaluation and the sensitivity and specificity of MRCP obtained with 3T scanners in cases of bile duct obstruction.

Material and methods

Ethical approval was obtained from our university. Hospital records of 48 patients whose MRCPs were performed in the Radiology Clinic and ERCPs were performed in the Gastroenterology Clinic consecutively with suspected choledocholithiasis were evaluated between May 2017 and October 2017. Seven patients considered with tumour by MRCP and ERCP and diagnosed histopathologically were excluded. Four of the patients with failed ERCP for different reasons were also excluded. In total, 37 patients who had MRCP and ERCP were included. The patients were evaluated by two experienced radiologists. The radiologists were blinded to each other and the diagnosis of the patients.

Choledochal pathology was divided into two groups depending on the presence of stones as “there is stone or not”. Extrahepatic bile duct diameters were measured. Gall bladder was examined for the presence of stones. Biochemical parameters such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), and total bilirubin values were recorded.

MRCP was performed with a 3-Tesla (Siemens Skyra, Erlangen, Germany) system using respiratory-triggered HASTE technique in axial and coronal planes and with a T2 SPACE sequence in the coronal plane. Images of the T2 SPACE sequence were then reconstructed to maximum intensity projection (MIP) images in the coronal plane with 10 degrees (totally 36 images). Sequence parameters are given in Table 1.

Table 1

Parameters of sequences used in magnetic resonance cholangiopancreatography

TR (msn)TE (msn)Slice thickness (mm)FOV (cm)
Axial HASTE160095537 × 29
Coronal HASTE1400108537 × 34
T2 SPACE4489702137 × 37

ERCP techniques were performed with a side-viewed Pentax ED 3490 duodenoscope (Tokyo, Japan). Bile ducts were cannulated with a guidewire by sphincterotomy. Images were obtained with nonionic contrast materials. In cases of the presence of a stone, it was retrieved with a balloon catheter.

Mann-Whitney U test was used to compare demographic and laboratory data. Cohen’s κ value was calculated for interobserver agreement. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were calculated separately for each observer. The average of both observers was calculated for comparison with other studies. All statistical analyses were done using SPSS software (IBM SPSS Statistics 20).


Seven patients who had MRCP-ERCP comparison were diagnosed with tumours and were excluded from the study. Four of the patients who had ERCP failure for other reasons were also excluded. The ERCP failure rate was 8.33%. The reasons for failure were as follows: fibrotic papilla, papillary oedema, the papilla could not be found in one patient with gastroenterostomy, and papilla was placed at the rim of duodenal diverticula in another patient.

Thirty-seven patients were included in the study population. The average age of the study population was 63.51 (14-91) years. Fifteen of the patients were male and 22 were female. The average age of the male patients was 68.67 (20-91) years and of the female patients was 60 (14-91) years. Demographic features and laboratory data are summarised in Table 2.

Table 2

Demographic, biochemical, and ultrasonographic data of the cases

No choledocholithiasis (n = 7) (Median, min, max)Choledocholithiasis (n = 30) (Median, min, max)p value
Age (year)56 (14-72)69.50 (27-91)0.029
Total bilirubin (mg/dl)1.70 (0.28-7.05)2.75 (0.49-11.45)0.406
AST (U/l)49 (28-257)65 (10-552)0.815
ALT (U/l)62 (20-307)95 (10-587)0.815
GGT (U/l)225 (19-546)250 (20-1397)0.410
ALP (U/l)102 (55-308)155 (23-667)0.178
Cholelithiasis (n)518
Cholecystectomies (n)212
CBD diameter (mm)5 (3-8)11.65 (6-23)< 0.001

[i] CBD – common bile duct, min – minimum, max – maximum

The average time between MRCP and ERCP was 5.46 (1-15) days. The median bile duct size of the seven patients whose MRCP and ERCP results were evaluated as normal was 5 mm (3-8 mm). The median bile duct size was 11.65 mm (6-23) in 30 patients with choledocholithiasis.

The agreement between the observers was analysed, and Cohen’s κ value was evaluated as 0.84. For two observers, the sensitivity of MRCP was 93% whereas the specificity was 75% for the first observer and 62% for the second. Sensitivity, specificity, accuracy, PPV, and NPV values are shown in Table 3.

Table 3

Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy values both observers

Sensitivity (%)Specificity (%)PPV (%)NPV (%)Accuracy (%)
Observer 19375937589
Observer 29362907186


In this study, MRCP was compared with ERCP, and the sensitivity of MRCP in patients with choledocholithiasis was found to be 93% and specificity 69%. The sensitivity of MRCP is reported as being between 27% and 100% in the literature [2,5,6]. In our study, the sensitivity of MRCP that we found was similar to that of the high-level sensitivity groups in studies in the literature. Some studies found the specificity of MRCP to be between 40% and 100%. In this perspective, in our study, the sensitivity result seems to be in the medium sensitivity group [1,4]. In a comparison of the specificity value with other series, we found a lower value because the first observer reported suspected stone in the bile ducts of two patients and the second observer in three patients. Both observers interpreted false positive stones in the same cases. The time between MRCP and ERCP of these patients was 3-5 days. There was a dark focus in the axial HASTE series in the central distal portion of the bile duct in two patients who had false positive choledocholithiasis as reported by both of the observers (Figure 1A). This dark focus was not seen in coronal HASTE and T2 SPACE images (Figure 1B-C). It is thought that it could be due to the flow because the location of this false image is in the central distal portion of bile duct and only seen in the axial plane. Millimetric stones and sludge were reported in the ERCP of false negative cases (Table 4).

Table 4

Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) reported in the literature for MRCP in patients with suspected choledocholithiasis

AuthorYearScanner (Tesla)nSensitivity (%)Specificity (%)PPV (%)NPV (%)
Present study20173T37936991.573
Makmun [1]20171.53181407450
Badger [2]**20161.5 or 34790869760
Aydelotte [3]20151.53690889764
Polistina [4]20151.511177.410010085
Richard* [5]2013NR7027833677
Demartine [6]20001.54010095.692.6100

* In this study, MRCP was compared with intraoperative cholangiography

** In this study, MRCP was compared with intraoperative cholangiography or ERCP

NR – not reported

Figure 1

A) There was a hypointensity in axial HASTE series in central portion of distal bile duct (choledoc: arrowhead) (gall bladder: open arrow). B, C) This hypointensity was not seen in coronal HASTE and T2 SPACE MIP images


We also examined the agreement between observers. Cohen’s κ value was calculated as 0.84. This value shows that the agreement between the observers is quite good. Although there are studies concerning interobserver agreement of MRCP sequences, there is no adequate evidence and discussion about interobserver agreement of MRCP in patients with suspected choledocholithiasis [8,9].

In the first evaluation of patients with suspected choledocholithiasis, blood tests (ALT, AST, GGT, ALP, and total bilirubin) and transabdominal ultrasonography (TAUS) should be performed [10]. Levels of cholestatic biochemical markers (GGT, ALP, and bilirubin) usually increase gradually, consistent with the duration and severity of biliary obstruction. However, these biochemical tests are not specific to choledocholithiasis and can increase in some other conditions like pancreatitis in the first line. No statistical significance was found in levels of biochemical tests in patients with choledocholithiasis and in patients without choledocholithiasis in this study. In the group of patients without choledocholithiasis, one patient had hepatitis and sludge in the gall bladder, one patient had cholecystitis, and two other patients had pancreatitis. The other three patients were investigated because of complaints that developed after cholecystectomy and the establishment of large bile duct in ultrasonography. The last patient had increased levels in biochemical tests but normalised in the following tests.

Normally the bile duct diameter is smaller than 6 mm [11]. A mild dilation is reported to be normal due to aging [12]. Biliary obstruction should be suggested when the bile duct diameter is over 8 mm in patients with normal gallbladder [13]. In the group of patients without choledocholithiasis in our study, the maximum bile duct diameter was evaluated as 8 mm; this was in the patient with cholecystectomy. TAUS has a low sensitivity in detecting CBD stones. However, it is more reliable in detecting dilation in the bile duct due to choledocholithiasis [14,15].

ERCP is the reference diagnostic method in biliary obstruction [16]. In patients with obstructive jaundice, the ERCP failure rate is about 6-7% [17]. The rate we found in our study was 8.33%. This rate is slightly higher than reported. ERCP is recommended in patients with cholelithiasis and with high risk of choledocholithiasis before the operation. In patients with ERCP failure, EUS and MRCP are recommended [10]. In our opinion, it seems more rational to perform MRCP before ERCP in order to give a broad overview and detect lesions other than choledocholithiasis.

There are some limitations in our study. Nonparametric tests were used for comparison of the groups when the number was limited in the group of patients without choledocholithiasis. There was a delay between MRCP and ERCP because it was a retrospective study. The average delay was 5.46 days and in some of the patients it prolonged to 15 days. During this time interval, although it is a low probability, the persistence of stones in the bile duct might have changed, and this situation might have caused false negative results.


As a result, in this study we found a high level of interobserver agreement in evaluating MRCP. MRCP has a high sensitivity in detecting choledocholithiasis. However, the specificity found in this study was comparatively low, and this may be due to artefacts caused by high magnetic field. Further long-term studies are needed.

Conflict of interest

The authors report no conflict of interest.



Makmun D, Fauzi A, Shatri H , authors. Sensitivity and specificity of magnetic resonance cholangiopancreatography versus endoscopic ultrasonography against endoscopic retrograde cholangiopancreatography in diagnosing choledocholithiasis: the Indonesian experience. Clin Endosc. 2017. 50:p. 486–490


Badger WR, Borgert AJ, Kallies KJ, Kothari SN , authors. Utility of MRCP in clinical decision making of suspected choledocholithiasis: An institutional analysis and literature review. Am J Surg. 2017. 214:p. 251–255


Aydelotte JD, Ali J, Huynh PT, et al. , authors. Use of magnetic resonance cholangiopancreatography in clinical practice: not as good as we once thought. J Am Coll Surg. 2015. 221:p. 215–219


Polistina FA, Frego M, Bisello M, et al. , authors. Accuracy of magnetic resonance cholangiography compared to operative endoscopy in detecting biliary stones, a single center experience and review of literature. World J Radiol. 2015. 28:p. 70–78


Richard F, Boustany M, Britt LD , authors. Accuracy of magnetic resonance cholangiopancreatography for diagnosing stones in the common bile duct in patients with abnormal intraoperative cholangiograms. Am J Surg. 2013. 205:p. 371–373


Demartines N, Eisner L, Schnabel K, et al. , authors. Evaluation of magnetic resonance cholangiography in the management of bile duct stones. Arch Surg. 2000. 135:p. 148–152


Merkle EM, Dale BM, Paulson EK , authors. Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am. 2006. 14:p. 17–26


Nandalur KR, Hussain HK, Weadock WJ, et al. , authors. Possible biliary disease: diagnostic performance of high-spatial-resolution isotropic 3D T2-weighted MRCP. Radiology. 2008. 249:p. 883–890


Sudholt P, Zaehringer C, Urigo C, et al. , authors. Comparison of optimized 3D-SPACE and 3D-TSE sequences at 1.5T MRCP in the diagnosis of choledocholithiasis. Rofo. 2015. 187:p. 467–471


Maple JT, Ben-Menachem T, Anderson MA, et al. , authors. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010. 71:p. 1–9


Parulekar SG , author. Ultrasound evaluation of bile duct size. Radiology. 1979. 133:p. 703–707


Bachar GN, Cohen M, Belenky A, et al. , authors. Effect of aging on the adult extrahepatic bile duct: a sonographic study. J Ultrasound Med. 2003. 22:p. 879–882


Baron RL, Stanley RJ, Lee JKT, et al. , authors. A prospective comparison of the evaluation of biliary obstruction using computed tomography and ultrasonography. Radiology. 1982. 145:p. 91–98


Lapis JL, Orlando RC, Mittelstaedt CA, et al. , authors. Ultrasonography in the diagnosis of obstructive jaundice. Ann Intern Med. 1978. 89:p. 61–63


Einstein DM, Lapin SA, Ralls PW, et al. , authors. The insensitivity of sonography in the detection of choledocholithiasis. Am J Roentgenol. 1984. 142:p. 725–728


Kaltenthaler EC, Walters SJ, Chilcott J, et al. , authors. MRCP compared to diagnostic ERCP for diagnosis when biliary obstruction is suspected: a systematic review. BMC Med Imaging. 2006. 6:p. 9


Giovannini M, Bories E, Napoleon B, et al. , authors. 855 multicenter randomized phase II study: percutaneous biliary drainage vs EUS guided biliary drainage: results of the intermediate analysis. Gastrointest Endosc. 2015. 81:p. 174

Copyright: © Polish Medical Society of Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0). License allowing third parties to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe